Cardinal Health, Inc. (CAH)

Schlusskurs vom Vortag:

$97.11

Offen:

$97.56

24-Stunden-Volumen:

1.65M

Marktkapitalisierung:

$24.04B

Einnahmen:

$220.57B

Nettoeinkommen (Verlust:

$552.00M

KGV:

161.80

EPS:

0.61

Netto-Cashflow:

$2.01B

1W Leistung:

+0.65%

1M Leistung:

-7.90%

6M Leistung:

-4.45%

1J Leistung:

+15.03%

1-Tages-Spanne:

$97.27

$99.07

52-Wochen-Spanne:

$80.90

$116.04

Cardinal Health, Inc. Stock (CAH) Company Profile

Firmenname

Cardinal Health, Inc.

Sektor

Healthcare (1211)

Branche

Medical Distribution (12)

Telefon

614-757-5000

Adresse

7000 Cardinal Place, Dublin, OH

Mitarbeiter

50,000

Twitter

@cardinalhealth

Nächster Verdiensttermin

2024-05-29

Neueste SEC-Einreichungen

CAH's Discussions on Twitter

Cardinal Health, Inc. Stock (CAH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-02-09	Hochstufung	Argus	Hold → Buy
2024-01-03	Eingeleitet	Barclays	Overweight
2023-12-14	Eingeleitet	Wells Fargo	Underweight
2023-07-10	Herabstufung	Evercore ISI	Outperform → In-line
2023-03-31	Eingeleitet	Citigroup	Neutral
2023-02-03	Hochstufung	Robert W. Baird	Neutral → Outperform
2022-11-04	Hochstufung	BofA Securities	Underperform → Neutral
2022-08-22	Fortgesetzt	Morgan Stanley	Overweight
2022-05-26	Herabstufung	Barclays	Overweight → Equal Weight
2022-05-18	Hochstufung	Evercore ISI	In-line → Outperform
2022-04-12	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2022-04-01	Fortgesetzt	Credit Suisse	Neutral
2021-08-06	Herabstufung	Deutsche Bank	Buy → Hold
2021-08-05	Herabstufung	BofA Securities	Buy → Underperform
2021-05-10	Herabstufung	Robert W. Baird	Outperform → Neutral
2021-01-08	Hochstufung	Wolfe Research	Underperform → Peer Perform
2020-11-02	Hochstufung	Barclays	Equal Weight → Overweight
2020-09-25	Hochstufung	Deutsche Bank	Hold → Buy
2020-07-20	Hochstufung	Guggenheim	Neutral → Buy
2020-05-15	Hochstufung	UBS	Neutral → Buy
2020-04-23	Fortgesetzt	Credit Suisse	Neutral
2020-03-20	Hochstufung	BofA/Merrill	Underperform → Buy
2020-02-12	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2020-02-07	Hochstufung	Robert W. Baird	Neutral → Outperform
2019-12-16	Herabstufung	Guggenheim	Buy → Neutral
2019-09-12	Eingeleitet	Deutsche Bank	Hold
2019-08-27	Herabstufung	Argus	Buy → Hold
2019-08-20	Hochstufung	Guggenheim	Neutral → Buy
2019-04-18	Eingeleitet	Guggenheim	Neutral
2019-01-17	Eingeleitet	UBS	Neutral
2018-11-16	Herabstufung	Leerink Partners	Outperform → Mkt Perform
2018-04-24	Hochstufung	Leerink Partners	Mkt Perform → Outperform
2018-04-02	Hochstufung	Argus	Hold → Buy
2018-03-08	Eingeleitet	Barclays	Equal Weight
2018-02-27	Fortgesetzt	BofA/Merrill	Underperform
2018-01-05	Eingeleitet	Evercore ISI	In-line

Alle ansehen

Cardinal Health, Inc. Aktie (CAH) Neueste Nachrichten

Mitsubishi UFJ Asset Management Co. Ltd. Reduces Stock Position in Cardinal Health, Inc. (NYSE:CAH) - MarketBeat

MarketBeat

Private Advisor Group LLC Lowers Holdings in Cardinal Health, Inc. (NYSE:CAH) - Defense World

Defense World

Cardinal Health (NYSE:CAH) Price Target Cut to $115.00 - MarketBeat

MarketBeat

Cardinal Health (CAH) Q2 Earnings and Revenues Surpass Estimates - Yahoo News UK

Yahoo News UK

Cardinal Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

MarketWatch

Cardinal Health acquires Olathe medical devices company - The Business Journals

The Business Journals

Finanzdaten der Cardinal Health, Inc.-Aktie (CAH)

Cardinal Health, Inc. (CAH) Umsatz 2024

Cardinal Health, Inc. (CAH) Nettogewinn 2024

Cardinal Health, Inc. (CAH) Free Cashflow 2024

Cardinal Health, Inc. (CAH) Gewinn je Aktie 2024